Clinical Trials Industry Pain Points, Jeeva Clinical SaaS solution and Value Propositions

Jeeva Founder and CEO, Dr Harsha Rajasimha shares his personal journey that led him to decide to dedicate his years of postdoctoral research experience at National Institutes of Health (NIH) and US Food and Drug Administration (FDA) to accelerate the development of life-saving therapies for rare and neglected diseases.

Jeeva aims to reduce the patients travel burden in clinical trials by 50% to 80% depending on the trial protocol and participant preferences. By improving the overall user experience for both the research teams and patients, the Jeeva Clinical SaaS solution is sure to cut the development timelines by 20% to 50%.  The modular solution allows the flexibility for a la carte or end-to-end workflow of a hybrid decentralized clinical trial configuration and experience.